Hemin promotes platelet activation and plasma membrane disintegration regulated by the subtilisin-like proprotein convertase furin
- PMID: 39530531
- DOI: 10.1096/fj.202400863RR
Hemin promotes platelet activation and plasma membrane disintegration regulated by the subtilisin-like proprotein convertase furin
Abstract
Platelet activation plays a critical role in thrombosis and hemostasis. Several pathophysiological situations lead to hemolysis, resulting in the liberation of free ferric iron-containing hemin. Hemin has been shown to activate platelets and induce thrombo-inflammation. Classical antiplatelet therapy failed to prevent hemin-induced platelet activation. Thus, the aim of the present study was to characterize the mechanism of hemin-induced platelet death (ferroptosis). We evaluated the in vitro effect of hemin on platelet activation, signaling, oxylipins, and plasma membrane destruction using light transmission aggregometry, ex vivo thrombus formation, multiparametric flow cytometry, micro-UHPLC mass spectrometry for oxylipin profiling, and scanning ion conductance microscopy (SICM). We found that hemin induces platelet cell death indicated by increased ROS levels, phosphatidyl serine (PS) exposure, and loss of mitochondrial membrane potential (ΔΨm). Further, hemin causes lipid peroxidation and generation of distinct oxylipins, which strongly affects plasma membrane integrity leading to generation of platelet-derived microvesicles. Interestingly, hemin-dependent platelet death (ferroptosis) is specifically regulated by the subtilisin-like proprotein convertase furin. In summary, platelet undergo a non-apoptotic cell death mediated by furin. Inhibition of furin may offer a therapeutic strategy to control hemin-induced thrombosis and thrombo-inflammation at a site of hemolysis.
Keywords: ferroptosis; furin; hemin; microvesicle; platelets.
© 2024 The Author(s). The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.
References
REFERENCES
-
- Koupenova M, Kehrel BE, Corkrey HA, Freedman JE. Thrombosis and platelets: an update. Eur Heart J. 2017;38(11):785‐791. doi:10.1093/eurheartj/ehw550
-
- Freedman JE. Molecular regulation of platelet‐dependent thrombosis. Circulation. 2005;112(17):2725‐2734. doi:10.1161/CIRCULATIONAHA.104.494468
-
- Swieringa F, Spronk HMH, Heemskerk JWM, van der Meijden PEJ. Integrating platelet and coagulation activation in fibrin clot formation. Res Pract Thromb Haemost. 2018;2(3):450‐460. doi:10.1002/rth2.12107
-
- Heemskerk JW, Mattheij NJ, Cosemans JM. Platelet‐based coagulation: different populations, different functions. J Thromb Haemost. 2013;11(1):2‐16. doi:10.1111/jth.12045
-
- Sang Y, Roest M, de Laat B, de Groot PG, Huskens D. Interplay between platelets and coagulation. Blood Rev. 2021;46:100733. doi:10.1016/j.blre.2020.100733
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources